載入...
Osimertinib as treatment for EGFR exon 20 insertion-positive lung adenocarcinoma
A 20-year-old woman was diagnosed with stage 4 lung adenocarcinoma with an epidermal growth factor receptor (EGFR) exon 20 insertion gene mutation. Although the patient underwent chemotherapy, her lesions progressed. Liquid biopsy for EGFR T790M mutation showed negative results. After administering...
Na minha lista:
| 發表在: | EXCLI J |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Leibniz Research Centre for Working Environment and Human Factors
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6806250/ https://ncbi.nlm.nih.gov/pubmed/31645848 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.17179/excli2019-1786 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|